From Lab Sample to Plant Brief: What Still Needs Validation

01 / EDITORIAL NOTE

A laboratory result is a bounded observation

A successful laboratory run answers a question about a specific formulation, in a specific small-scale arrangement, over a short period. That is valuable evidence. It is not a demonstration that a commercial line will produce the same product at a different scale. The plant brief should preserve the boundary: what was tested, in which equipment, with which measurement, and what remains open.

The most common error is not a wrong number; it is a missing qualifier. “The product withstood the thermal treatment” becomes “the product is stable” and then “the line is validated”. Each step drops a condition. A written handoff should make those conditions visible before anyone budgets for a production change or promises a customer a launch date.

This is not a reason to distrust laboratory work. It is a reason to describe it precisely. A trial that names its equipment, flow, thermal history and sampling boundary gives the plant team a real starting point. A trial that reports only a temperature gives them a slogan.

02 / EDITORIAL NOTE

Compare flow regime and equipment geometry

Laboratory units typically run at low flow through small-diameter passages with short holding sections. A production line may run at a different flow, with a different tube or plate geometry and a different holding arrangement. Those changes affect velocity profiles, residence-time distribution, heat-transfer coefficients and pressure drop. They also change how the product behaves at connections, valves and instrumentation.

The plant brief should ask for the actual geometry: pipe diameters and lengths, number of passes, holding-section volume and the position of instruments. A piping and instrumentation diagram and an equipment drawing are more useful than a photograph. If the trial used a tubular unit and the plant is considering a plate exchanger, the comparison is a change of equipment, not a scale-up of the same experiment.

Residence time is not a single number in real equipment. A calculated holding time based on volume and flow assumes ideal plug flow. In practice, connections, valves, dead legs and inlet or outlet geometry create a distribution of times. The production validation should establish the residence-time distribution for the actual line rather than importing a laboratory estimate.

Flow regime also changes mixing and heat transfer. A laboratory trial that worked at low Reynolds number may not represent a turbulent production run. The brief should state the flow and temperature conditions and ask the engineering team to compare the relevant dimensionless groups, not only the nominal capacity of the equipment.

03 / EDITORIAL NOTE

Review particles, fouling and run duration

Particulate or pulpy products add questions that a clear-liquid trial does not answer. Particle size, shape, concentration and settling behaviour influence pumping, heat transfer and the risk of blocking. A laboratory run with a strained sample says little about a formulation that carries pieces.

Fouling is time-dependent. A short trial may show stable heat transfer while a longer production run accumulates deposits that change pressure drop and temperature. The plant brief should define the intended run length, the cleaning interval and the product-side inspection points. It should also ask how the trial cleaning procedure compares with the production cleaning circuit, because a laboratory flush is not the same operation as a validated clean-in-place cycle.

Product changeover is another scale-dependent matter. The laboratory unit may be flushed between small batches; a plant line may run one formulation for hours. Transition material, product loss and cleaning verification need separate planning. A laboratory sample that looks correct at the outlet does not show how the line behaves after a long run.

04 / EDITORIAL NOTE

Define the aseptic collection boundary

A laboratory filling cabinet provides a controlled workspace, but a production aseptic filler is a different system with its own sterilization, environmental control and container or closure handling. The plant brief should state which boundary the trial actually tested: open collection, collection in a cabinet, or a fully aseptic transfer. These are different claims, and they need different evidence.

Container and closure preparation, filling environment, operator intervention and integrity testing are part of the production boundary. If the trial used pre-sterilised laboratory containers, the production plan still needs a validated container and closure system and a documented filling procedure. The FDA inspection guide for aseptic processing and packaging treats the sterile system as an integrated boundary rather than a single machine.

Records should connect the sample to the boundary. Note the cabinet operating state, the container type and preparation, and the time between filling and closure. These details let a reviewer see whether a sample represents the process step it is supposed to represent. Without them, a sample may be technically interesting but impossible to place in the production sequence.

05 / EDITORIAL NOTE

List the production evidence still required

A plant brief should separate equipment selection from process validation. Equipment selection can start from the product, the intended duty and the available utilities. Process validation needs a product-specific scheduled process, established by a qualified process authority where the regulation applies, with critical factors and records defined. The UNIDO guide to small-scale fruit and vegetable processing discusses production methods and quality-assurance context, but it does not substitute for that product-specific work.

Depending on the product and market, the evidence list can include heat penetration or temperature distribution studies, residence-time distribution, microbiological challenge or inactivation validation, container closure integrity, shelf-life testing and cleaning validation. The list should name who is responsible for each item and which document will demonstrate it.

Engineering evidence belongs alongside the process evidence: drawings, instrument schedules, calibration, alarm and interlock testing, utility capacity and operator procedures. A laboratory trial can inform these documents, but it cannot replace them. The useful question is not whether the laboratory result is “close enough”; it is which production condition has been demonstrated and which one is still an assumption.

06 / EDITORIAL NOTE

Write the handoff as questions, not conclusions

A useful plant brief is a set of explicit questions: which conditions must be reproduced, which may differ, and what evidence will show that the difference is acceptable. A table with columns for the trial observation, the production assumption, the evidence needed and the owner is more useful than a narrative that implies equivalence.

The laboratory phase has done its job when it narrows the uncertainty and produces samples worth testing. The production phase begins when the remaining uncertainties are named. Keeping that line clear protects the value of the trial and gives the plant team a realistic starting point for engineering, validation and commercial planning.

For a laboratory equipment enquiry, the practical next step is to describe the product, the intended production question and the evidence the plant will require. That context helps separate a laboratory configuration decision from a validation programme that must be planned separately. It also keeps the equipment conversation honest about what a bench-scale unit can and cannot demonstrate.